R. Lai

发表

Understanding Delayed T-Cell Priming, Lung Recruitment, and Airway Luminal T-Cell Responses in Host Defense against Pulmonary Tuberculosis

Z. Xing, C. R. Shaler, C. Horvath, 2012, Clinical & developmental immunology.

CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine–Induced T Cells to Both the Lung Parenchyma and Airway

M. Jordana, S. Kunkel, M. Jeyanathan, 2017, The Journal of Immunology.

Single-dose mucosal immunotherapy with chimpanzee adenovirus-based vaccine accelerates TB disease control and limits its rebound following antibiotic cessation.

M. Jeyanathan, S. Afkhami, Z. Xing, 2019, The Journal of infectious diseases.

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity

J. Schertzer, Clinton S. Robbins, M. Jeyanathan, 2018, Cell.

Host genetic background is a barrier to vaccine-induced protection against infection

Martin T. Ferris, D. Lauffenburger, C. Sassetti, 2022, bioRxiv.

CD11b+ Dendritic Cell–Mediated Anti–Mycobacterium tuberculosis Th1 Activation Is Counterregulated by CD103+ Dendritic Cells via IL-10

M. Jeyanathan, C. Kaushic, S. Afkhami, 2018, The Journal of Immunology.

Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells

M. Jordana, A. Ashkar, M. Jeyanathan, 2013, Mucosal Immunology.

Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation

S. Afkhami, Z. Xing, Yushi Yao, 2019 .

Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity

M. Jeyanathan, Z. Xing, C. R. Shaler, 2012, Mucosal Immunology.

Host genetic background is a barrier to broadly effective vaccine protection: Relevance to BCG and Mycobacterium tuberculosis Infection

Martin T. Ferris, D. Lauffenburger, C. Sassetti, 2022, bioRxiv.

Airway Macrophages Mediate Mucosal Vaccine–Induced Trained Innate Immunity against Mycobacterium tuberculosis in Early Stages of Infection

M. Jeyanathan, S. Afkhami, Z. Xing, 2020, The Journal of Immunology.

Functionally Overlapping Variants Control Tuberculosis Susceptibility in Collaborative Cross Mice

T. A. Bell, Martin T. Ferris, R. Baker, 2019, mBio.

Functionally overlapping variants control TB susceptibility in Collaborative Cross mice

T. A. Bell, Martin T. Ferris, R. Baker, 2019, bioRxiv.

GRP78 and CHOP modulate macrophage apoptosis and the development of bleomycin‐induced pulmonary fibrosis

C. Shimbori, M. Kolb, M. Inman, 2016, The Journal of pathology.

Limited recognition of Mycobacterium tuberculosis-infected macrophages by polyclonal CD4 and CD8 T cells from the lungs of infected mice

A. Sette, S. Behar, C. L. Arlehamn, 2019, bioRxiv.

Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice

T. Ottenhoff, H. Ertl, K. Franken, 2023, npj Vaccines.

Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection

H. Ertl, J. Gauldie, M. Medina, 2015, Mucosal Immunology.

Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine

F. Vahedi, A. Ashkar, M. Jeyanathan, 2017, The Journal of infectious diseases.

Restoration of innate immune activation accelerates Th1‐cell priming and protection following pulmonary mycobacterial infection

A. Ashkar, M. Jeyanathan, Z. Xing, 2014, European journal of immunology.

Role of B Cells in Mucosal Vaccine–Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis

M. Jeyanathan, S. Afkhami, Z. Xing, 2015, The Journal of Immunology.

A novel virus-vectored respiratory mucosal vaccine enhances anti-tuberculosis immunity in a humanized model system

F. Vahedi, A. Ashkar, M. Jeyanathan, 2017 .

Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo.

H. Ertl, E. Cranston, M. Thompson, 2017, Vaccine.

Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses.

C. Hogaboam, M. Jeyanathan, Z. Xing, 2013, The American journal of pathology.

Limited recognition of Mycobacterium tuberculosis-infected macrophages by polyclonal CD4 and CD8 T cells from the lungs of infected mice

A. Sette, C. L. Lindestam Arlehamn, S. Behar, 2019, Mucosal Immunology.

Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model

M. Jeyanathan, S. Afkhami, Z. Xing, 2015, PloS one.

Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments

M. Jeyanathan, S. Afkhami, Z. Xing, 2015, European Respiratory Review.

Host genetic background is a barrier to broadly effective vaccine–mediated protection against tuberculosis

D. Lauffenburger, C. Sassetti, G. Beamer, 2023, The Journal of clinical investigation.